Cardioprotective Effect of Endomorphin-1 In Vitro: the Role of Intracellular Messengers

Area of Science:

• Cardiology
• Pharmacology
• Molecular Biology

Background:

• Global ischemia followed by reperfusion causes significant cardiac injury.
• Opioid receptors, particularly μ2-opioid receptors, are present in the heart.
• Modulating cardiac opioid receptors may offer therapeutic benefits during ischemia-reperfusion events.

Purpose of the Study:

• To investigate the effect of the selective μ2-opioid receptor agonist endomorphin-1 on cardiac function during reperfusion.
• To determine the impact of endomorphin-1 on myocardial levels of inositol triphosphate and diacylglycerol.
• To assess whether endomorphin-1 enhances cardiac tolerance to reperfusion injury.

Main Methods:

• Global ischemia (45 min) followed by reperfusion (30 min) was induced in isolated male Wistar rat hearts.
• Endomorphin-1 (152 nmol/liter) was administered at the start of the reperfusion period.
• Myocardial concentrations of inositol triphosphate and diacylglycerol were quantified.

Main Results:

• Endomorphin-1 administration significantly improved cardiac contractility parameters during the reperfusion phase.
• Perfusion with endomorphin-1 led to a 4.1-fold increase in myocardial inositol triphosphate levels.
• Myocardial diacylglycerol concentrations were elevated 6-fold in hearts treated with endomorphin-1.

Conclusions:

• Stimulation of cardiac μ2-opioid receptors with endomorphin-1 confers protection against reperfusion injury.
• Endomorphin-1 enhances cardiac tolerance by modulating intracellular signaling pathways involving inositol triphosphate and diacylglycerol.
• Targeting cardiac μ2-opioid receptors represents a potential therapeutic strategy for managing myocardial ischemia-reperfusion damage.